Rasagiline Tablet
Product Images NDC 42571-221

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 42571-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline Lbl A

Rasagiline Tablets 0.5 mg oral tablets packaging label showing 30 tablets per package. The label includes storage instructions, manufacturer Micro Labs Limited in India, and Micro Labs USA, Inc. in Somerset, NJ. The NDC 42571-220-30 is visible along with a barcode. The label indicates it is a prescription-only drug.*

FDA Label Image

Rasagiline Lbl B

Rasagiline Tablets 1 mg oral tablets label for a 30-tablet package from Micro Labs Limited. The label includes dosage strength, Rx only designation, and manufacturer information for Micro Labs Limited in India and Micro Labs USA, Inc. in New Jersey. Storage instructions and NDC 42571-221-30 are also visible.*

FDA Label Image

Structure (Rasagiline Structure)

Chemical structure of Rasagiline mesylate, the active ingredient in RASAGILINE tablets. The structure shows a bicyclic system attached to an amino group and a propargyl side chain, with an associated mesylate (CH3SO3H) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.